Cargando…

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials

BACKGROUND: Infections with HIV still represent a major human health problem worldwide and a vaccine is the only long-term option to fight efficiently against this virus. Standardized assessments of HIV-specific immune responses in vaccine trials are essential for prioritizing vaccine candidates in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schultz, Anke, Koch, Stefanie, Fuss, Martina, Mazzotta, Angela S., Sarzotti-Kelsoe, Marcella, Ozaki, Daniel A., Montefiori, David C., von Briesen, Hagen, Zimmermann, Heiko, Meyerhans, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531445/ https://www.ncbi.nlm.nih.gov/pubmed/23300558 http://dx.doi.org/10.1371/journal.pone.0051715

Ejemplares similares

Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks
por: Schultz, Anke, et al.
Publicado: (2018)

Short Communication: Potential Risk of Replication-Competent Virus in HIV-1 Env-Pseudotyped Virus Preparations
por: Bilska, Miroslawa, et al.
Publicado: (2017)

International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials
por: Ozaki, Daniel A., et al.
Publicado: (2012)

Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3- and a Trimer-Specific gp41 Antibody
por: Trott, Maria, et al.
Publicado: (2014)

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides
por: Gomara, Maria J., et al.
Publicado: (2019)

P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
por: Todd, CA, et al.
Publicado: (2009)

Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies
por: Bharadwaj, Pranay, et al.
Publicado: (2020)

Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells
por: Neubauer, J. C., et al.
Publicado: (2016)

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2012)

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy
por: Hu, Xintao, et al.
Publicado: (2017)

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors
por: Siegert, Sandra, et al.
Publicado: (2005)

sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates
por: Lagenaur, Laurel A, et al.
Publicado: (2010)

Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques
por: Shen, Xiaoying, et al.
Publicado: (2017)

Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy
por: Koch, Peter, et al.
Publicado: (2009)

Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
por: Hraber, Peter, et al.
Publicado: (2017)

Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
por: Seaman, Michael S., et al.
Publicado: (2020)

HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
por: Tagliamonte, Maria, et al.
Publicado: (2012)

A Replication-Competent HIV Clone Carrying GFP-Env Reveals Rapid Env Recycling at the HIV-1 T Cell Virological Synapse
por: Wang, Lili, et al.
Publicado: (2021)

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
por: Brown, Eric P., et al.
Publicado: (2018)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2010)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2011)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
por: Chen, Y, et al.
Publicado: (2012)

Unlocking HIV-1 Env: implications for antibody attack
por: Richard, Jonathan, et al.
Publicado: (2017)

The HIV Env Glycoprotein Conformational States on Cells and Viruses
por: Zhao, Connie, et al.
Publicado: (2022)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
por: Antanasijevic, Aleksandar, et al.
Publicado: (2021)

Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies
por: Vaine, Michael, et al.
Publicado: (2010)

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
por: Suryawanshi, Poonam, et al.
Publicado: (2021)

Regulation of ABC Drug Efflux Transporters in Human T-Cells Exposed to an HIV Pseudotype
por: Whyte-Allman, Sana-Kay, et al.
Publicado: (2021)

Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue
por: Arakelyan, Anush, et al.
Publicado: (2017)

Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants
por: Bagaya, Bernard S., et al.
Publicado: (2015)

Determinants in HIV-2 Env and tetherin required for functional interaction
por: Exline, Colin M, et al.
Publicado: (2015)

Structure and immune recognition of trimeric prefusion HIV-1 Env
por: Pancera, Marie, et al.
Publicado: (2014)

Visualization of the HIV-1 Env glycan shield across scales
por: Berndsen, Zachary T., et al.
Publicado: (2020)

The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis
por: Pérez-Yanes, Silvia, et al.
Publicado: (2022)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2009)

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism
por: Jeanne, Nicolas, et al.
Publicado: (2015)

CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo
por: Tsao, Li-Chung, et al.
Publicado: (2016)

Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV
por: Sadraeian, Mohammad, et al.
Publicado: (2021)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3bttsfi17nv7io3td9m9tmol4